Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique
Conditions: Moderate Depression; Major Depressive Disorder; Severe Depression Interventions: Device: 4 session rTMS; Device: 6 session rTMS; Device: 8 session rTMS; Device: 10 session rTMS; Device: sham rTMS Sponsors: Changping Laboratory; Wuhan Mental Health Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials

Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet ®
Conditions: Fed Conditions Interventions: Drug: Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg); Drug: Galvumet ® Film Coated Tablets (850 mg / 50 mg) Sponsors: Reseach Laboratory of Clinical and Experimental Pharmacology; Soci été Arabe des Industries Pharmaceutiques SAIPH - Tunisia; Centre National Chalbi Belkahia de Pharmacovigilance CNPV - Tunisia Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials

Future Patient - Telerehabilitation of Patients With Atrial Fibrillation
Conditions: Atrial Fibrillation Interventions: Device: Telerehabilitation Sponsors: Aalborg University; Department of Cardiology, Viborg Regional Hospital; Department of Cardiology, Silkeborg Regional Hospital; Center for Innovative Medical Technologies (CIMT), Odense University Hospital; Laboratory for Welfare Technology, Department of Health Science and Technology, Aalborg University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials

Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2
Conditions: SARS-CoV-2 Infection; COVID-19; Coronavirus Interventions: Device: eBAM Cov Testing Sponsors: Centre Hospitalier Universitaire de N īmes; University of Nimes; brains ' laboratory sas, FRANCE Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials

ImGTS for Patients With Cerebral Palsy and With Mobility Limitations (Phase 2)
Conditions: Cerebral Palsy Interventions: Other: Virtual reality Sponsors: Augmented eXperience E-health Laboratory Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials

Serum Retinoic Acid Induced Protein 14 (RAI14) and Metastasis Associated Cancer Colon -1 (MACC-1) in Breast Cancer
Conditions: Breast Cancer Interventions: Diagnostic Test: laboratory test (RAI14 and MACC-1 ) Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials

Expression Analysis of Urinary Exosome miR-142-3p in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value
Conditions: Urinary Exosomes , miRNAS, Diabetic Nephropathy Interventions: Other: Grouping based on previous laboratory results, no intervention. Sponsors: Yipeng Liu Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials

Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value
Conditions: Diabetic Nephropathy Interventions: Other: Grouping based on previous laboratory results, no intervention. Sponsors: Yipeng Liu Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials

rTMS Therapy for Treatment-Resistant Depression With Different Targets Guided by pBFS
Conditions: MDD; Major Depressive Disorder; Treatment Resistant Depression Interventions: Device: active rTMS Sponsors: Changping Laboratory Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials

A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
Conditions: Purine-Pyrimidine Metabolism; Metabolic Disease Sponsors: National Human Genome Research Institute (NHGRI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials

Prospective Study of the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
Conditions: Purine-Pyrimidine Metabolism; Metabolic Disease Sponsors: National Human Genome Research Institute (NHGRI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials

pBFS-guided cTBS Combined With iTBS Over the Superior Frontal Gyrus for Aphasia After Ischemic Stroke
Conditions: Stroke, Ischemic; Aphasia Interventions: Device: active cTBS combined with iTBS; Device: sham cTBS combined with iTBS Sponsors: Changping Laboratory Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials

Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine
Conditions: Hypothyroidism Interventions: Other: Single extra blood draw and completion of single questionnaire; Other: Single blood draw and completion of single questionnaire Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials

ImGTS for Patients With Behavioral and Psychological Symptoms of Dementia (Phase 2)
Conditions: Dementia Alzheimers Interventions: Other: Virtual reality Sponsors: Augmented eXperience E-health Laboratory Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials

Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet ®
Conditions: Fed Conditions Interventions: Drug: Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) Sponsors: Reseach Laboratory of Clinical and Experimental Pharmacology; La Soci été Arabe des Industries Pharmaceutiques-Tunisie; Centre National Chalbi Belkahia de Pharmacovigilance-Tunisie Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials